TraceLink Secures Merit Award for Healthcare Innovation with AI-Powered Product Availability Intelligence Solution

2023-11-16
TraceLink Wins Prestigious Merit Award for Pioneering AI-Driven Solution to Predict Drug Shortages 90 Days in Advance
BOSTON, Nov. 16, 2023 /PRNewswire/ -- TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 291,000 healthcare and life sciences entities through its B2N Integrate-Once™ network, is proud to announce that its innovative Product Availability Intelligence (PAI) solution has been recognized with a Bronze award by the prestigious Merit Awards for Healthcare Innovation. Product Availability Intelligence leverages the collective intelligence of the TraceLink network to flag drug shortages up to 90 days in advance so they can be successfully mitigated.
The Merit Awards for Healthcare celebrate advancements in healthcare, honoring organizations that have demonstrated exceptional use of technology to meet a wide range of healthcare needs—in this case, addressing the critical challenge of escalating drug shortages in the United States.
TraceLink customers are excited to partner on innovations that improve patient care.
"Recognizing the critical challenge of drug shortages in healthcare, Boston Medical Center is committed to excellence in patient care. This commitment has led us to collaborate with TraceLink," said M. Ross Casey, PharmD, MBA, CSP, Director of Supply Chain & 340B Optimization at Boston Medical Center. "Together, we're implementing forward-thinking strategies to anticipate and protect our patients from the impact of drug shortages."
In 2023, the ASHP Drug Shortages Survey Report highlighted a concerning peak, with 309 active drug shortages—the highest in nearly a decade. TraceLink Product Availability Intelligence successfully predicted 70% of these shortages. Customers of PAI have harnessed our platform to avert shortages for hundreds of thousands of patients, exemplifying our commitment to safeguarding patient health and ensuring medication availability.
The Merit Awards for Healthcare acknowledge the relentless efforts and achievements of global industries and the markets they serve, spotlighting companies that have significantly contributed to the market's growth. TraceLink's recognition at the annual event underscores the company's role as a pioneer in the digital transformation of healthcare.
"This award is a testament to the hard work and dedication of our team who are committed to driving innovation in healthcare," said Shabbir Dahod, President and CEO of TraceLink. "As we celebrate this achievement, we remain focused on advancing our technology to meet the complex challenges of today's global healthcare supply chain."
To learn more about PAI Product Availability Intelligence visit: https://www.tracelink.com/products/intelligence-and-analytics/product-availability-intelligence
For the full list of winners visit: https://www.businesswire.com/news/home/20231107462086/en/
About TraceLink
TraceLink is a leading provider of digital supply chain solutions that deliver unprecedented visibility, enabling companies to protect patients, ensure compliance, and optimize their supply chain operations. The TraceLink cloud-based platform provides a single point of information sharing and collaboration for all supply chain partners, leveraging advanced analytics and machine learning to drive actionable insights. With TraceLink, businesses can achieve end-to-end supply chain visibility and forge stronger connections with their partners, ensuring the availability and integrity of lifesaving medications for patients worldwide.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。